Green Cross Health (NZSE:GXH) Marketable Securities: NZ$0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NZSE:GXH Green Cross Health Ltd NZSE:GXH
57 GF Score
Price NZ$1.95
GF Value NZ$1.08
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Green Cross Health Marketable Securities?

Green Cross Health NZSE:GXH +1.04% 57 Marketable Securities is NZ$0.0 Mil as of Mar. 2026. GuruFocus rates NZSE:GXH with a GF Score™ of 57/100 and a GF Value™ of NZ$1.08 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Green Cross Health's Marketable Securities for the quarter that ended in Mar. 2026 was NZ$0.0 Mil.

Green Cross Health  (NZSE:GXH) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Green Cross Health Marketable Securities Related Terms

Green Cross Health Marketable Securities Historical Data

* Premium members only.

The historical data trend for Green Cross Health's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Green Cross Health Marketable Securities Chart

Green Cross Health Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Green Cross Health Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NZSE:GXH
57GF Score
Green Cross Health Ltd NZSE:GXH
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Green Cross Health Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NZ$0.0 Mil mean?
Green Cross Health (NZSE:GXH) has a Marketable Securities of NZ$0.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Green Cross Health and its competitors.
Is Green Cross Health's Marketable Securities too high?
Green Cross Health's current Marketable Securities is NZ$0.0 Mil. Overall, Green Cross Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's Marketable Securities compare to competitors?
Green Cross Health's Marketable Securities of NZ$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Green Cross Health and its competitors. Green Cross Health's current Marketable Securities is NZ$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$1.95 — trading 80.6% above its estimated fair value. The current Marketable Securities is NZ$0.0 Mil. Green Cross Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current Marketable Securities is NZ$0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Green Cross Health (NZSE:GXH) Overvalued in 2026?

Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued. The current stock price of NZ$1.95 is trading 80.6% above its estimated GF Value™ of NZ$1.08. GuruFocus considers Green Cross Health to be Significantly Overvalued.

Key valuation signals for NZSE:GXH:

  • Marketable Securities: NZ$0.0 Mil
  • GF Value™: NZ$1.08 vs. price of NZ$1.95 (80.6% above fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Green Cross Health Business Description

Address 602 Great South Road, Ellerslie, Ground Floor, Building B, Millennium Centre, Auckland, NTL, NZL, 1051
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
57GF Score

Get the complete analysis for NZSE:GXH

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$1.95
Price
NZ$1.08
GF Value